Department of Public Health, College of Medicine and Health Sciences, Injibara University, Injibara, Ethiopia.
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Injibara University, Injibara, Ethiopia.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2350815. doi: 10.1080/21645515.2024.2350815. Epub 2024 May 17.
COVID-19 vaccine acceptance is crucial for patients with chronic diseases, but previous studies in Ethiopia have yielded inconsistent and inconclusive findings. To fill this gap, we conducted a systematic review and meta-analysis following established guidelines. Our search included relevant articles published between 2019 and 2023 from various sources. We assessed study heterogeneity and publication bias, and performed subgroup and sensitivity analyses. Our findings indicate that the COVID-19 vaccine acceptance rate among patients with chronic diseases in Ethiopia was 55.4%. We also found that good knowledge and a favorable attitude toward the vaccine were positively associated with the acceptance rate. Based on these results, we recommend that healthcare professionals, policymakers, and healthcare guide developers should work more to address the relatively low acceptance rate. Improving the knowledge and attitude further about the COVID-19 vaccines is crucial. Future research should include community-based and qualitative studies to enhance our understanding of vaccines acceptance.
COVID-19 疫苗的接受度对慢性病患者至关重要,但以前在埃塞俄比亚进行的研究得出的结果并不一致且没有定论。为了填补这一空白,我们按照既定的指南进行了系统的回顾和荟萃分析。我们的搜索包括 2019 年至 2023 年期间来自各种来源的相关文章。我们评估了研究的异质性和发表偏倚,并进行了亚组和敏感性分析。我们的研究结果表明,埃塞俄比亚慢性病患者对 COVID-19 疫苗的接受率为 55.4%。我们还发现,对疫苗的良好认知和积极态度与接受率呈正相关。基于这些结果,我们建议医疗保健专业人员、政策制定者和医疗保健指南制定者应更加努力解决接受率相对较低的问题。进一步提高对 COVID-19 疫苗的认识和态度至关重要。未来的研究应包括基于社区的定性研究,以增强我们对疫苗接受度的理解。